INVA
Innoviva Inc

1,521
Mkt Cap
$2.38B
Volume
1.09M
52W High
$22.46
52W Low
$16.52
PE Ratio
15.98
INVA Fundamentals
Price
$22.20
Prev Close
$22.28
Open
$22.29
50D MA
$18.69
Beta
0.35
Avg. Volume
766,128.13
EPS (Annual)
$0.3621
P/B
1.65
Rev/Employee
$2.93M
Loading...
Loading...
News
all
press releases
Innoviva (NASDAQ:INVA) Hits New 1-Year High - Here's Why
Innoviva (NASDAQ:INVA) Sets New 12-Month High - Here's Why...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
HC Wainwright Issues Negative Estimate for Innoviva Earnings
Innoviva, Inc. (NASDAQ:INVA - Free Report) - Equities research analysts at HC Wainwright dropped their Q4 2025 EPS estimates for shares of Innoviva in a note issued to investors on Monday, November...
MarketBeat·11h ago
News Placeholder
Q2 Earnings Forecast for Innoviva Issued By HC Wainwright
Innoviva, Inc. (NASDAQ:INVA - Free Report) - Investment analysts at HC Wainwright lowered their Q2 2026 EPS estimates for Innoviva in a note issued to investors on Monday, November 10th. HC...
MarketBeat·1d ago
News Placeholder
Cantor Fitzgerald Comments on Innoviva FY2026 Earnings
Innoviva, Inc. (NASDAQ:INVA - Free Report) - Analysts at Cantor Fitzgerald raised their FY2026 earnings estimates for Innoviva in a research note issued to investors on Thursday, November 6th. Cantor...
MarketBeat·4d ago
News Placeholder
Innoviva (NASDAQ:INVA) Shares Gap Up After Analyst Upgrade
Innoviva (NASDAQ:INVA) Shares Gap Up After Analyst Upgrade...
MarketBeat·6d ago
News Placeholder
Cantor Fitzgerald Issues Positive Forecast for Innoviva (NASDAQ:INVA) Stock Price
Cantor Fitzgerald lifted their price target on Innoviva from $29.00 to $31.00 and gave the company an "overweight" rating in a report on Thursday...
MarketBeat·6d ago
News Placeholder
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results, Beats Expectations By $0.62 EPS
Innoviva (NASDAQ:INVA - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $1.08 earnings per share for the quarter, beating analysts...
MarketBeat·7d ago
News Placeholder
Innoviva (INVA) Q3 Earnings and Revenues Beat Estimates
Innoviva (INVA) delivered earnings and revenue surprises of +134.78% and +14.78%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates
Pfizer (PFE) delivered earnings and revenue surprises of +31.82% and +0.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
AbbVie (ABBV) Q3 Earnings and Revenues Surpass Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of +5.08% and +1.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago

Latest INVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.